341 related articles for article (PubMed ID: 18691485)
1. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia.
Cheong HS; Kang CI; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
Am J Med; 2008 Aug; 121(8):709-14. PubMed ID: 18691485
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
Cheong HS; Kang CI; Kwon KT; Heo ST; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
J Antimicrob Chemother; 2007 Dec; 60(6):1355-60. PubMed ID: 17923453
[TBL] [Abstract][Full Text] [Related]
4. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?
Schechner V; Nobre V; Kaye KS; Leshno M; Giladi M; Rohner P; Harbarth S; Anderson DJ; Karchmer AW; Schwaber MJ; Carmeli Y
Clin Infect Dis; 2009 Mar; 48(5):580-6. PubMed ID: 19191643
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED.
Kang CI; Chung DR; Peck KR; Song JH;
Am J Emerg Med; 2012 Sep; 30(7):1169-75. PubMed ID: 22030178
[TBL] [Abstract][Full Text] [Related]
6. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
Kang CI; Kim SH; Kim HB; Park SW; Choe YJ; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):745-51. PubMed ID: 12955633
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of Pseudomonas aeruginosa bacteremia among Gram-negative bacterial infections in non-neutropenic patients with solid tumor.
Joo EJ; Kang CI; Ha YE; Kim J; Kang SJ; Park SY; Lee NY; Wi YM; Chung DR; Peck KR; Song JH
J Infect; 2011 Sep; 63(3):207-14. PubMed ID: 21777616
[TBL] [Abstract][Full Text] [Related]
10. [Pseudomonas aeruginosa bacteremia in patients with HIV infection: clinicoepidemiologic study of 17 episodes].
Salavert Lletí S; Navarro Ibáñez V; Roig Rico P; Bretón Martínez JR; Ponz Díez F; López Aldeguer J; Gobernado Serrano M
Rev Clin Esp; 1996 Oct; 196(10):684-91. PubMed ID: 9005471
[TBL] [Abstract][Full Text] [Related]
11. Different clinical presentation of community-onset bacteremia among neutropenic adults in the ED.
Lee CC; Hsieh CC; Lee NY; Chan TY; Hong MY; Chi CH; Ko WC
Am J Emerg Med; 2015 Jul; 33(7):907-12. PubMed ID: 25959847
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT
Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of Enterobacter bacteremia among patients admitted to the ED.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Am J Emerg Med; 2012 Jan; 30(1):165-9. PubMed ID: 20951533
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for Pseudomonas aeruginosa bacteremia in Thai patients.
Siripassorn K; Santiprasitkul S; Udompanthurak S; Thamlikitkul V
J Med Assoc Thai; 2002 Oct; 85(10):1095-9. PubMed ID: 12501901
[TBL] [Abstract][Full Text] [Related]
15. Burden of community-onset Escherichia coli bacteremia in seniors.
Jackson LA; Benson P; Neuzil KM; Grandjean M; Marino JL
J Infect Dis; 2005 May; 191(9):1523-9. PubMed ID: 15809912
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
Chen SC; Lawrence RH; Byth K; Sorrell TC
Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia.
Cheong HS; Kang CI; Wi YM; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
Eur J Clin Microbiol Infect Dis; 2008 Dec; 27(12):1219-25. PubMed ID: 18575908
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED.
Lee CC; Lee CH; Hong MY
Am J Emerg Med; 2012 Jul; 30(6):852-60. PubMed ID: 21855263
[TBL] [Abstract][Full Text] [Related]
20. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
